Search

Jun 2, 2024
The CEO of Arcus Biosciences talks TIGIT, adenosine, and HIF-2α at #ASCO24
Terry Rosen describes data presented at ASCO for TIGIT in upper GI cancers, adenosine in late state colorectal cancer, and non-ASCO data...

Jun 3, 2023
Dissecting the TIGIT battleground at #ASCO23
Arcus Biosciences CEO Terry Rosen describes the ARC-7 TIGIT data update that was presented at #ASCO23.